London, UK (PRWEB) July 19, 2012
Among the CIS countries, Russia, Ukraine and Kazakhstan are considered to be the largest and most promising in terms of growth markets for the innovative pharmaceuticals and generic drugs. The regulatory changes within these countries have affected the way companies conduct business and thus they have to chose solutions to adapt their business models to the ever changing marketplace.
New report "Generic and Innovative Drugs Market in CIS Countries 2012. Russia, Ukraine and Kazakhstan" elaborated by PMR has been recently published by Market Publishers Ltd.
Title: Generic and Innovative Drugs Market in CIS Countries 2012. Russia, Ukraine and Kazakhstan
Published: June, 2012
Price: US$ 2,800
The report provides complete coverage of current conditions in Russia, Ukraine and Kazakhstan in the field of innovative and generic drugs. It offers analysis of the complex legal environments in each country, with detailed accounts of the effects of recent and pending legislative activity on market development.
It provides extensive coverage of pricing and reimbursement regulations for each of the covered countries, including VAT rates and mark-ups. The report also covers market leaders, supplying details on the largest producers in each country and for the overall CIS market. Forecasts through 2014 offer a deep view at the future of these markets.
I. REPORT METHODOLOGY
II. EXECUTIVE SUMMARY
III. CHARACTERISTICS OF GENERIC AND INNOVATIVE DRUG MARKETS IN RUSSIA, UKRAINE AND KAZAKHSTAN
IV. BEST-SELLING DRUGS IN CIS COUNTRIES
V. DRUG PATENT EXPIRY AND DATA EXCLUSIVITY PERIODS IN CIS
VI. COUNTERFEIT MEDICINES IN CIS
VII. REIMBURSEMENT AND PRICING POLICIES IN RUSSIA, UKRAINE AND KAZAKHSTAN
VIII. KEY MANUFACTURERS IN CIS COUNTRIES
IX. LIST OF GRAPHS
X. LIST OF TABLES
XI. ABOUT PMR
XII. CONTACT PMR
More new market research reports by the publisher can be found at PMR page.